Wendy Hill has over 20 years experience in clinical development and regulatory affairs in a variety of therapeutic areas including cancer, inflammation, infectious and cardiovascular disease. She has played a key role in preparing the clinical plan and protocols for PDC's lead candidate. Previous positions include Director of Research at Knoll Canada, Senior Director, Clinical Research at GlycoDesign and R&D Director, Inflammation and Neurology at Amgen Canada. Since founding Gap Strategies in the spring of 2004, she has been assisting biotechnology companies prepare and execute strategic clinical and regulatory development plans for products and devices.

Monika Chabicovsky founded MC Toxicology Consulting, a Vienna based Consulting Company, in 2006. Her company's core expertise comprises the non-clinical development of biologics and small molecules focusing primarily on toxicology related questions and regulatory affairs.

Monika holds a PhD in cancer research from the University of Vienna, a Master in Toxicology and a Diploma in Regulatory Affairs (University of Cardiff).

Christian Soschner, Mag. (MBA), has been in the finance business for over 11 years. Previously he headed and built up the finance & controlling department at Nabriva, an Austrian biotech company, responsible for strategic business planning, reporting, annual financial statements, risk management, treasury and contracting. Prior to this he held management positions in the finance area at Agrana, Atos Origin, Austrian Post and NPOs. He holds a degree in economics from the University of Economy, Graz and is certified Management Coach and Martial Arts Trainer.